Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.51
(0.73%)
CNY 5.51
(0.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 301.48 Million CNY | -8.25% |
| 2022 | 328.59 Million CNY | -8.32% |
| 2021 | 358.42 Million CNY | 6.13% |
| 2020 | 337.73 Million CNY | 33.07% |
| 2019 | 253.8 Million CNY | -7.75% |
| 2018 | 275.13 Million CNY | -8.92% |
| 2017 | 302.07 Million CNY | 12.84% |
| 2016 | 267.7 Million CNY | 11.12% |
| 2015 | 240.92 Million CNY | 18.3% |
| 2014 | 203.65 Million CNY | 5.47% |
| 2013 | 193.09 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 88.05 Million CNY | 41.89% |
| 2024 Q3 | 121.92 Million CNY | 218.2% |
| 2024 Q2 | 38.31 Million CNY | -56.49% |
| 2023 Q3 | 116.35 Million CNY | 182.28% |
| 2023 Q4 | 62.06 Million CNY | -46.66% |
| 2023 FY | 301.48 Million CNY | -8.25% |
| 2023 Q1 | 81.85 Million CNY | 94.84% |
| 2023 Q2 | 41.21 Million CNY | -49.64% |
| 2022 Q3 | 148.32 Million CNY | 201.39% |
| 2022 Q1 | 89.04 Million CNY | 3.53% |
| 2022 FY | 328.59 Million CNY | -8.32% |
| 2022 Q4 | 42 Million CNY | -71.68% |
| 2022 Q2 | 49.21 Million CNY | -44.74% |
| 2021 FY | 358.42 Million CNY | 6.13% |
| 2021 Q4 | 86.01 Million CNY | -27.95% |
| 2021 Q1 | 82.85 Million CNY | 132.9% |
| 2021 Q2 | 70.17 Million CNY | -15.31% |
| 2021 Q3 | 119.38 Million CNY | 70.13% |
| 2020 Q4 | 35.57 Million CNY | -75.89% |
| 2020 FY | 337.73 Million CNY | 33.07% |
| 2020 Q3 | 147.53 Million CNY | 162.67% |
| 2020 Q2 | 56.16 Million CNY | -42.94% |
| 2020 Q1 | 98.44 Million CNY | 250.76% |
| 2019 Q1 | 94.83 Million CNY | 186.77% |
| 2019 Q4 | 28.06 Million CNY | -70.57% |
| 2019 Q2 | 35.55 Million CNY | -62.51% |
| 2019 Q3 | 95.35 Million CNY | 168.22% |
| 2019 FY | 253.8 Million CNY | -7.75% |
| 2018 Q4 | 33.06 Million CNY | 0.0% |
| 2018 FY | 275.13 Million CNY | -8.92% |
| 2018 Q1 | 109.31 Million CNY | 0.0% |
| 2017 Q2 | 77.34 Million CNY | 0.0% |
| 2017 Q1 | 77.34 Million CNY | 20.24% |
| 2017 FY | 302.07 Million CNY | 12.84% |
| 2016 Q1 | 69.52 Million CNY | 0.0% |
| 2016 Q3 | 64.32 Million CNY | -7.47% |
| 2016 Q2 | 69.52 Million CNY | 0.0% |
| 2016 Q4 | 64.32 Million CNY | 0.0% |
| 2016 FY | 267.7 Million CNY | 11.12% |
| 2015 FY | 240.92 Million CNY | 18.3% |
| 2014 FY | 203.65 Million CNY | 5.47% |
| 2013 FY | 193.09 Million CNY | 0.0% |